HER2-Positive Breast Cancer: A Guide Through An Evolving Treatment Landscape

Downloadable slides with expert insights on the latest clinical data and expert recommendations to optimize clinical outcomes for your patients with HER2-positive breast cancer.

Share

Program Content

Activities

HER2 BC + Brain Mets
Managing Patients With HER2+ Breast Cancer and Brain Metastasis: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Testing for HER2 BC
HER2 Testing and Treatment Decisions In Breast Cancer: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Treating HER2+ EBC
Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Treating HER2+ MBC
Therapeutic Strategies for HER2-Positive Metastatic Breast Cancer: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 03, 2021

Expires: February 02, 2022

<i>EP</i>: HER2+ BC Tx
ExpressPoints: HER2-Positive Breast Cancer: A Guide Through an Evolving Treatment Landscape
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 09, 2021

Expires: February 08, 2022

Faculty

cover img faculity

Jame Abraham, MD, FACP

Chairman
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Puma Biotechnology, Inc.